Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy

BACKGROUND:Data regarding the effectiveness of adalimumab (ADA) in the treatment of perianal fistula in patients with Crohn’s disease (CD) naive to antitumor necrosis factor (TNF) therapy are scarce. AIM:To assess the effectiveness of ADA in the treatment of perianal fistulas in CD patients naive to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 2015-01, Vol.49 (1), p.34-40
Hauptverfasser:	Castaño-Milla, Carlos, Chaparro, María, Saro, Cristina, Barreiro-de Acosta, Manuel, García-Albert, Ana M, Bujanda, Luis, Martín-Arranz, María D, Carpio, Daniel, Muñoz, Fernando, Manceñido, Noemí, García-Planella, Esther, Piqueras, Marta, Calvet, Xavier, Cabriada, José L, Botella, Belén, Bermejo, Fernando, Gisbert, Javier P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adult Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Crohn Disease - complications Crohn Disease - drug therapy Crohn Disease - surgery Cutaneous Fistula - drug therapy Cutaneous Fistula - etiology Female Humans Magnetic Resonance Imaging Male Middle Aged Rectal Fistula - drug therapy Rectal Fistula - etiology Retrospective Studies Severity of Illness Index Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!